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Abstract
Mannose-binding lectin (MBL) is a humoral pattern-recognition molecule important for host defense. Although recent
genetic studies suggest an involvement of MBL/MASP2-associated pathways in Chagas’ disease, it is currently unknown
whether MBL plays a role in host resistance to the intracellular protozoan Trypanosoma cruzi, the causative agent of Chagas’
disease. In this study we employed MBL
2/2 mice to assess the role of MBL in resistance to experimental infection with T.
cruzi. T. cruzi infection enhanced tissue expression of MBL both at the mRNA and protein level. Similarly, symptomatic acute
Chagas’ disease patients displayed increased serum concentrations of MBL compared to patients with indeterminate,
asymptomatic forms of the disease. Furthermore, increased parasite loads in the blood and/or tissue were observed in
MBL
2/2 mice compared to WT controls. This was associated with reduced systemic levels of IL-12/23p40 in MBL
2/2 mice.
Importantly, MBL
2/2 mice infected with a cardiotropic strain of T. cruzi displayed increased myocarditis and cardiac fibrosis
compared to WT controls. The latter was accompanied by elevated hydroxyproline content and mRNA levels of collagen-1
and -6 in the heart. These observations point to a previously unappreciated role for MBL in regulating host resistance and
cardiac inflammation during infection with a major human pathogen.
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Introduction
Collectins, with their collagenous backbone and globular
carbohydrate-recognition domains, are major players in innate
immunity. Mannose-binding lectin (MBL) is an important
member of the collectin family and functions as a humoral
pattern-recognition receptor (PRR) [1]. It is a serum opsonin that
binds to microbial cell-wall saccharides present in various
organisms, including gram-positive and -negative bacteria, yeast,
protozoan parasites and viruses, and initiates the lectin pathway of
complement activation [1]. A seminal study found that low MBL
levels account for a common defect in opsonization of yeast in
patients prone to recurrent infections [2]. This discovery
subsequently led to a vast array of clinical studies associating
MBL deficiency with susceptibility to infection [3]. Human genetic
studies have since established a relationship between MBL allelic
variants, serum levels of MBL and susceptibility to infection [4].
Studies on the biology of MBL and its role in infection have
been greatly facilitated by the recent generation of gene-targeted
mice lacking functional MBL [5]. Mice present two functional
MBL proteins, MBL-A and MBL-C, while humans display only
one [6]. The two murine forms are highly homologous to human
MBL and both bind to carbohydrate surfaces and activate
complement [7]. Mice deficient in both MBL-A and MBL-C
and consequently lacking all circulating MBL (MBL
2/2 mice)
have been instrumental in unraveling a role for this molecule in
host resistance to Staphylococcus aureus [5,8], Herpes simplex virus-2
[9] and Candida albicans [10]. In vitro studies on S. aureus also
revealed a role for MBL in modulating infection-induced cytokine
and chemokine responses [11]. Moreover, isolated reports
implicate MBL in regulating inflammation during post-burn
injury [12], acute septic peritonitis [13] and kidney ischemia
reperfusion injury [14]. However, there is a paucity of information
regarding the role of MBL during protozoan infections and its
inflammatory sequelae.
PLOS ONE | www.plosone.org 1 November 2012 | Volume 7 | Issue 11 | e47835Trypanosoma cruzi is an intracellular protozoan parasite. It is the
causative agent of Chagas’ disease, which affects roughly 17
million people throughout Central and South America [15]. Host
control of this parasite is strongly coupled to cell-mediated,
adaptive immune responses, in particular to T cells producing
interferon (IFN)-c [16]. A role for innate immunity in triggering
such responses is evident from defects in adaptive immunity and
host resistance to T. cruzi in mice with selective ablation of toll-like
receptors (TLR) or the TLR adaptor molecule MyD88 [17,18].
The contribution of humoral responses to protection against T.
cruzi has also been studied. In this context, complement has been
shown to bind to the surface of trypomastigotes, the blood-stage,
infectious form of T. cruzi, but this form of the parasite
demonstrates significant resistance to direct complement-mediated
lysis [19]. Thus, while MBL has been shown to bind directly to T.
cruzi trypomastigotes or their surface proteins in vitro [20,21],
activation of the lectin pathway is nevertheless inhibited [21].
Importantly, single nucleotide polymorphism (SNP) studies in
humans indicate a possible function of MBL or MBL-associated
pathways such as MASP2 in regulating T. cruzi-induced cardio-
myopathy [22,23]. In addition to complement, it is also possible
that MBL could influence heart inflammation through an indirect
mechanism. Regardless, how MBL regulates host responses to T.
cruzi remains to be investigated in vivo.
In the present study, we report that MBL
2/2 mice display a
moderate increase in susceptibility to infection with both reticulo-
and cardiotropic strains of T. cruzi accompanied by reduced
systemic levels of IL-12/23p40. In addition, MBL
2/2 mice exhibit
increased inflammatory responses in the heart following infection
with the cardiotropic strain of the parasite. Our data suggest that
MBL is part of an important humoral pattern recognition system
involved in host protective responses that help contain parasite
replication in situ and regulate immunopathology.
Results
MBL is Induced Following T. cruzi Infection
Previous studies have reported increased expression of MBL
in response to inflammatory stimuli such as LPS or azocasein
[24,25] but less is known regarding its induction in response to
live organisms. To investigate whether MBL is up-regulated
during T. cruzi infection in vivo, mRNA expression of this lectin
was assessed following parasite infection. Increased mRNA
accumulation of both MBL-A and MBL-C was observed in
spleen after i.p. infection with 1000 trypomastigotes of the
reticulotropic Y strain of T. cruzi, with MBL-A induction being
higher than MBL-C (Figure 1A). The observed increase in MBL
mRNA in the spleen from parasite-infected mice was consistent
with immunofluorescence staining for MBL-C in the same
tissue, where MBL expression localized to both red and white
pulp (Figure 1B). Interestingly, Chagas’ disease patients with
acute symptoms displayed increased quantities of MBL protein
in the serum when compared to indeterminate, asymptomatic
Chagas’ disease subjects (Figure 1C, *p=0.0266). Although the
TLR-adaptor MyD88 is a major regulator of innate and
adaptive immune responses against T. cruzi [17,18], parasite-
triggered MBL mRNA expression appeared to be independent
of MyD88 (Figure 1A). Altogether, these data suggest that acute
infection with T. cruzi enhances expression of MBL in humans
as well as in mice.
MBL
2/2 Mice Display Impaired Resistance to Y strain
T. cruzi Infection Accompanied by a Reduction in IL-12/
23p40 Production
Given the increased expression of MBL during infection, we
investigated the role of this molecule in host resistance to T. cruzi.
WT and MBL
2/2 animals were infected with T. cruzi Y strain and
followed for parasitemia and tissue parasite loads. Interestingly,
MBL
2/2 animals presented an increase in parasite numbers in the
blood in comparison to WT mice (Figure 2A). Statistically
significant differences in T. cruzi DNA load were not observed
between WT and MBL
2/2 mice although there was a tendency of
higher parasite loads in MBL
2/2 mice (Figure 2B). Reduced
serum levels of IL-12/23p40 but not of IFN-c were evident in
infected MBL
2/2 mice (Figure 2C). Consistent with normal
production of IFN-c, mortality was not observed in MBL-deficient
animals.
Increased Parasite Load, Cardiomyopathy and Fibrosis in
MBL
2/2 Mice Infected with T. cruzi Colombiana Strain
Although experimental infection with the Y strain leads to only
minor cardiac involvement [26], MBL
2/2 mice displayed a higher
number of amastigote nests in that tissue (data not shown). This
suggested a potential involvement of MBL in regulating parasite
replication in the heart. To address this and the role of MBL in
cardiac inflammation triggered by T. cruzi, we infected WT and
MBL
2/2 mice with the cardiotropic Colombiana strain of T. cruzi.
This strain is known to induce significant heart pathology in
experimental animals [27]. While T. cruzi Colombiana-infected
MBL
2/2 animals displayed similar parasitemia to infected WT
controls (Figure 3A), parasite loads in the hearts of MBL
2/2 mice
were elevated compared to WT controls at the peak of acute
infection (Figure 3B). Consistent with the results observed during
infection with the Y strain of the parasite, T. cruzi Colombiana-
infected MBL
2/2 mice displayed reduced systemic levels of IL-
12/23p40 but not IFN-c (Figure 3C). There was a tendency for
increased mortality in MBL
2/2 mice compared to infected WT
controls, but this difference was not statistically significant (data
not shown).
Myocarditis and cardiac fibrosis are hallmarks of the pathology
observed in patients suffering from Chagas’ disease and in mice
chronically infected with T. cruzi Colombiana. Such pathology
lead to arrhythmias and heart failure in Chagas’ patients [28]. To
assess the degree of cardiac disease in MBL
2/2 mice chronically
infected with T. cruzi, we performed histopathological analysis of
hearts from Colombiana-infected WT and MBL
2/2 mice. We
found a major increase in both myocarditis and fibrosis in the
heart of MBL
2/2 mice 5 weeks after infection (Figure 4A).
Myocarditis and fibrosis were mostly sub-epicardial, in the third or
fourth of the myocardium nearest the heart surface, in agreement
with previous histological data [27].
Augmented fibrosis in MBL
2/2 mice was further corroborated
by increased hydroxyproline content as well as Collagen-1 and -
6 mRNA in the hearts from infected MBL
2/2 but not WT
animals (Figure 4B–C). Based on these and the above
observations we conclude that MBL is an important regulator
of heart inflammatory responses to T. cruzi.
Discussion
A series of in vivo studies have recently implicated MBL in host
control of bacterial, viral and fungal infections but the importance
of MBL in host resistance to protozoa remains uncharacterized. In
this study we addressed the role of MBL during experimental
infection with reticulo- and cardiotropic strains of the protozoan
MBL in T. cruzi Infection
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infection induces expression of both MBL-A and MBL-C through
a MyD88-independent pathway and that MBL deficiency leads to
a moderate increase in susceptibility to T. cruzi. The latter
observation was associated with augmented tissue pathology and
fibrosis. This is to our knowledge the first indication that MBL is
important in mediating host resistance and in regulating inflam-
matory responses to an intracellular protozoan pathogen in vivo.
The liver is a major site of MBL synthesis under both steady-
state and inflammatory conditions [24]. Detection of MBL-A and
MBL-C has also been reported in various other tissues in the
absence of exogenous stimuli [29,30], but less is known regarding
the extrahepatic expression of MBL during inflammation and
infection. We observed increased expression of MBL-A and MBL-
C in the spleen following live challenge with T. cruzi. Contrary to
previous observations showing that MBL was present primarily in
the marginal zone of naı ¨ve spleen [30], during T. cruzi infection we
found MBL-C expression localized not only in the white pulp but
also decorating vessels within the red pulp.
During T. cruzi infection, TLR triggering is important for
production of IL-12/23p40, the ensuing Th1 response and
consequently, host control of infection [31]. Interestingly, we
found reduced levels of systemic IL-12/23p40 in T. cruzi-infected
MBL
2/2 mice. However, in spite of a higher parasite burden,
MBL
2/2 animals did not manifest enhanced mortality relative to
WT controls. So while MBL-dependent mechanisms are involved
host resistance against T. cruzi, other factors are clearly also
important. Consistent with this, MyD88
2/2 and bradykinin
receptor
2/2 mice infected with T. cruzi both display impaired
IL-12/23p40 and IFN-c production, as well as increased mortality
[17,32]. Thus, MBL-dependent regulation of IL-12/23p40
production is likely dispensable in the presence of other innate
recognition systems such as TLRs and bradykinin, which are
sufficient for mounting a protective Th1 response. This in turn is
Figure 1. T. cruzi infection induces MBL expression in vivo. WT and MyD88
2/2 mice were infected with trypomastigotes of the Y strain of T.
cruzi and 9 days after infection, MBL-A and MBL-C mRNA accumulation was determined in spleens from infected and uninfected animals by real-time
PCR (A). Detection of MBL-C protein was also performed by immunofluorescence microscopy in splenic sections obtained from WT mice infected as
above (B). Micrograph shows MBL-C (red) and B220 (blue) staining in both the red (RP) and white pulp (WP). Scale bar, 100 mm. Infected MBL
2/2
spleens were included as a control. All panels shown are representative of 2 independent experiments using 3 to 4 mice per group. Bars indicate the
standard error of the mean (SEM). Sera from patients with acute, chronic or indeterminate Chagas’ disease were assayed for MBL as described in
Material and Methods (C). *, Indicates statistically significant differences between acute vs indeterminate Chagas’ disease groups.
doi:10.1371/journal.pone.0047835.g001
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between T. cruzi-infected WT and MBL
2/2 mice.
The inflammatory response that follows T. cruzi infection is
important for host resistance but also contributes to the pathology
observed in Chagas’ disease [33]. A role for MBL as a modulator
of inflammatory responses and cardiovascular disease is becoming
increasingly evident. A correlation between increased MBL levels
and coronary artery disease and myocardial infarction exists in
men [34]. A role for MBL has also been demonstrated in ruptured
atherosclerotic plaques [35]. This is at variance with our
observations in T. cruzi where cardiac pathology is increased in
the absence of MBL. Increased tissue damage observed in our
model could thus be a consequence of increased parasite
replication in situ in the absence of MBL. Corroborating this,
some MBL-deficient patients have an increased risk of dying from
Figure 2. Role of MBL in host resistance to T. cruzi Y strain infection. WT or MBL
2/2 mice were infected with trypomastigotes of the
reticulotropic, Y strain of T. cruzi and monitored daily for parasitemia and mortality (A). Symbols represent the mean of 10 animals per group. At the
indicated time points after infection, levels of parasite DNA in the spleen were quantified by real-time PCR (B). Serum levels of IL-12/23p40 and IFN-c
were determined by ELISA 8 days after infection (C). Each symbol in (B) and (C) corresponds to an individual animal, dashed lines the mean of each
group and solid lines the standard error of the mean (SEM). The experiments shown are representative of at least two performed. *, Indicates
statistically significant differences between groups.
doi:10.1371/journal.pone.0047835.g002
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aureus [36].
Increased T. cruzi loads in MBL
2/2 mice are strongly in accord
with recent genetic studies showing that low-responser MBL and
MASP-2 genotypes in humans are overrepresented among patients
with Chagas’ disease [22,23] and Chagas’ cardiomyopathy [22].
The exact mechanism by which MBL regulates host control of T.
cruzi growth was however not formally addressed in this study.
Because the surface of trypomastigotes contains several molecules
capable of interfering with the actions of complement [20,37,38],
direct complement-mediated killing of trypomastigotes seems
unlikely. This is the case even though the lectin pathway of
Figure 3. Role of MBL in host resistance to T. cruzi Colombiana strain infection. WT or MBL
2/2 mice were infected with trypomastigotes of
the cardiotropic, Colombiana strain of T. cruzi and monitored weekly for parasitemia and mortality (A). Symbols represent the mean of 9 to 10 animals
per group. 5 wks after infection, levels of parasite DNA in the heart were quantified by real-time PCR (B) and serum levels of IL-12/23p40 and IFN-c
determined by ELISA (C). Each symbol in (B) and (C) corresponds to an individual animal, dashed lines the mean of each group and solid lines the
standard error of the mean (SEM). The experiments shown are representative of two performed. *, Indicates statistically significant differences
between groups.
doi:10.1371/journal.pone.0047835.g003
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MBL, due to the presence of ficolins [39]. On the other hand, the
intracellular amastigote form of T. cruzi is highly sensitive to
complement [19] and MBL has been shown to bind to amastigote
forms of Trypanosoma [40] as well as Leishmania [41]. Interestingly,
amastigotes can be released together with trypomastigotes when
infected host cells rupture [42,43]. These amastigotes are infectious
and capable of sustaining the T. cruzi life cycle [42,43,44]. Thus,
impaired complement-mediated clearance of amastigotes in the
absence of MBL would generate an additional source of infectious
organisms in the host, leading to an overall increase in parasite
burden in MBL
2/2 mice. In fact, progressive accumulation of
amastigote-derived antigens and pro-inflammatory molecules has
been implicated in the immunopathology of Chagas’ disease [45],
thus corroborating our finding of enhanced fibrosing myocarditis in
MBL
2/2 mice. Since it remains unknown if ficolins bind
amastigotes, and whether the phenotype of MBL
2/2 mice reflects
an actual deficiency in complement activation, it would be
interesting in future studies to investigate the outcome of T. cruzi
Figure 4. Enhanced cardiac pathology and fibrosis in MBL
2/2 infected with T. cruzi Colombiana strain. WT and MBL
2/2 mice were
infected with trypomastigotes of the Colombiana strain of T. cruzi and hearts from these animals obtained 5 weeks after infection. Hearts were
formalin-fixed, paraffin embedded, stained with H&E or Gomori’s trichrome and scored for pathology and fibrosis, respectively, as described under
Materials and Methods (A). Right panels show micrographs of Gomori’s trichrome staining for each group. Bars indicate the standard error of the
mean (SEM). Uninfected, or WT and MBL
2/2 mice infected as in (A) were harvested 5 wks later for determination of hydroxyproline content in total
heart (B). Each symbol corresponds to an individual animal, dashed lines represent the mean of each group and solid lines the standard error of the
mean (SEM). Heart samples from uninfected controls or from WT and MBL
2/2 mice infected as in (A) were obtained and mRNA accumulation of
Collagen-1, -3 and -6 determined by real-time PCR (C). The experiments shown are representative of two performed. *, Indicates statistically
significant differences between infected WT and MBL
2/2 groups.
doi:10.1371/journal.pone.0047835.g004
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2/2 mice [46], which are entirely deficient in
the lectin pathway of complement activation.
We have demonstrated that MBL expression is also enhanced in
acutely T. cruzi-infected, symptomatic patients. Our data supports
recent reports showing that SNPs in the human MBL gene may be
associated with susceptibility to T. cruzi [22,23]. Collectively, these
observations highlight the need for confirmatory experiments on
the expression of MBL in additional and larger patient cohorts
with Chagas’ disease. Genetic variations in both MBL and ficolin-
2 have recently been associated with both visceral and cutaneous
leishmaniasis [47,48]. Thus, it will be important to follow up our
observations made in T. cruzi-infected mice with robust clinical
studies of MBL polymorphisms and clinical endpoints in Chagas’
disease patients. Clinical investigations together with continued
dissection of MBL-regulated cardiac pathology in the mouse
model of infection will surely lead to an enhanced understanding
of the role played by MBL in the outcome of T. cruzi infection.
Materials and Methods
Mice
Ethics statement. This study was performed in accordance
with the recommendations in the Guide for the Care and Use of
Laboratory Animals of the NIH (Bethesda, MD) and AVMA
guidelines for Euthanasia. Animals were bred and maintained
under specific pathogen-free conditions at an AALAC-accredited
facility at the NIAID under the animal-study proposal LPD14E,
approved by the Institutional Animal Care and Use Committee
(IACUC) of the NIH. All efforts were made to minimize suffering.
Mice double deficient in MBL-A and MBL-C (MBL
2/2) have
been previously described [5] as have MyD88
2/2 mice [49].
MBL-deficient animals were backcrossed onto a C57Bl/6
background for 10 generations. MBL deficiency was confirmed
by PCR (data not shown). C57Bl/6 and Swiss Webster mice were
purchased from Taconic (Taconic Farms, Germantown, NY).
C57Bl/6 mice were used as wild-type (WT) controls. Sex-matched
animals between 8 and 12 wk old were used in all experiments.
Patients
Ethics statement. All patients and control subjects have
been informed of the study and have given written consent for
blood sampling. The UFSC Medical Ethics Committees have
approved the study protocol (UFSC- 144/2004).
Sera from symptomatic patients diagnosed with chronic (n=10)
or acute (n=10) Chagas’ disease were selected. AIDS, diabetes,
hepatitis, hypertension, pregnancy, and alcoholism were exclusion
criteria. All patients included in the study have been confirmed by
parasitological, serological and PCR assays for T. cruzi infection.
Ten indeterminate asymptomatic T. cruzi-infected individuals were
included in the control group.
Parasites and Experimental Infection with T. cruzi
Blood-stage trypomastigote forms of the Y [50] and Colombi-
ana [27] strains of Trypanosoma cruzi, both kindly obtained from
Drs. Fuyuki Tokumasu (Laboratory of Malaria and Vector
Research, NIAID/NIH), were maintained by serial passages in
Swiss Webster outbred mice. For infections, mice were intraper-
itoneally inoculated with 1000 trypomastigotes of the Y or
Colombiana strain of parasites. Parasitemia was determined using
5 ml of whole blood drawn from the tail vein by Brener’s method
[51].
Serum Cytokine and MBL Measurements
IFN-c and IL-12/23p40 were measured in the serum of naı ¨ve
and T. cruzi-infected mice by sandwich ELISA as previously
described [52]. MBL was quantified in the serum of Chagas’
disease patients by ELISA (Hycult, HK323) following the
manufacturer’s protocol.
Gene Expression Measurement by Real-time PCR
Total RNA was isolated from infected and naı ¨ve heart using the
RNeasy kit (Qiagen, Valencia, CA) according to the instructions of
the manufacturer and 1 mg of total RNA reverse-transcribed into
cDNA using M-MLV reverse transcriptase (Promega, Madison,
WI). Real-time PCR was performed on an ABI Prism 7900
sequence detection system (Applied Biosystems, Foster City, CA)
using SYBR Green PCR Master Mix. The relative amount of gene
expression was determined by the comparative threshold cycle
method as described by the manufacturer, whereby data for each
sample were normalized to hypoxanthine phosphoribosyltransfer-
ase (HPRT) and the gene of interest expressed either as a fold
change compared to uninfected controls or presented without
normalization (arbitrary units). The following primer pairs were
used:
for HPRT, GTT GGT TAC AGG CCA GAC TTT GTT G
(forward) and
GAG GGT AGG CTG GCC TAT AGG CT (reverse);
for MBL-A, GCT CCT TTA CTC TAA AGA AAC CCT
AGT (forward) and
TCA CCA CAC ACA GAA GGA CAG (reverse);
for MBL-C, AGG GAG AAA AGG GAG AAC CA (forward)
and
CCT GGG GGT CCT GTA GGT (reverse);
for Collagen 1, AAC TGG ACT GTC CCA ACC CC
(forward) and
TCC CTC GAC TCC TAC ATC TTC TG (reverse);
for Collagen 3, AAC CTG GTT TCT TCT CAC CC TTC
(forward) and
ACT CAT AGG ACT GAC CAA GGT GG (reverse);
for Collagen 6, CGC CCT TCC CAC TGA CAA (forward)
and
GCG TTC CCT TTA AGA CAG TTG AG (reverse).
Quantification of Parasite Tissue Loads by Real-time PCR
Real-time PCR for parasite quantification was performed as
previously described [53], with minor modifications. Briefly, at
different time-points after infection, DNA was extracted from
heart or spleen using a DNeasy kit (Qiagen). Real-time PCR using
50 ng of total DNA was performed on an ABI PRISM 7900
sequence detection system (Applied Biosystems) using SYBR
Green PCR Master Mix according to the manufacturer’s
recommendations. The equivalence of host DNA in the samples
was confirmed by measurement of genomic IL-12/23p40 PCR
product levels in the same samples. Purified T. cruzi DNA,
obtained from trypomastigote cultures maintained in vitro, was
sequentially diluted for standard curve generation in aqueous
solution containing equivalent amounts of DNA from uninfected
mouse tissues. The following primers were used: for T. cruzi
minicircle specific-primers, GCT CTT GCC CAC AMG GGT
GC, where M=A or C (S35-forward) and CCA AGC AGC GGA
TAG TTC AGG (S36-reverse) for genomic IL-12/23p40, GTA
GAG GTG GAC TGG ACT CC (forward) and CAG ATG TGA
GTG GCT CAG AG (reverse).
MBL in T. cruzi Infection
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Hearts from WT and MBL
2/2 mice infected with Colombiana
strain of T. cruzi were harvested 5 wks after infection and fixed in
10% neutral-buffered formalin. Hearts were then paraffin-
embedded, sectioned and stained with hematoxylin/eosin
(H&E), picro-sirius red or Gomori’s Trichrome (Histoserv,
Germantown, MD). Slides were examined under double-blinded
conditions by a pathologist (A. W. C). Infiltrates were graded 1 to
4+on the basis of the density of cells and extent of the infiltrate. A
single row of inflammatory cells was rated 1+and clusters of 3- to
4-cell thick and involving 10% of the myocardial area were graded
4+. Infiltrates extending into the myocardium from the epicardial
and endocardial infiltrates were graded as part of the latter
infiltrates. Interstitial fibrosis between myocardial fibers based on
picro-sirius or Gomori’s Trichrome stainings were also graded 1 to
4+.
Hydroxyproline Measurements
Hearts from WT and MBL
2/2 mice infected with Colombiana
strain of T. cruzi were obtained 5 weeks after infection and used to
estimate collagen as hydroxyproline by method B of Bergman and
Loxley as previously described [54].
Immunofluorescence Microscopy
Spleens were excised from naı ¨ve and Y-strain infected animals,
fixed overnight with 4% paraformaldehyde/PBS followed by
dehydration in 30% sucrose/PBS prior to embedding in Tissue-
Tek OCT freezing media (Sakura Finetek, Torrance, CA). Twenty
micron-thick sections were cut on a CM3050s cryostat (Leica
Microsystems, Bannockburn, IL) and adhered to Superfrost Plus
slides (VWR, West Chester, PA). Sections were permeabilized and
blocked in PBS containing 0.3% Triton X-100 (Sigma) and 10%
donkey serum (Jackson Immunoresearch). This was followed by
overnight incubation at 4uC with AlexaFluor 488-conjugated rat
anti-CD4 (RM4-5), AlexaFluor 647-conjugated rat anti-B220
(RA3-6B2, both from BD Biosciences, San Diego, CA) and
unconjugated, polyclonal goat anti-MBL-C (Santa Cruz Biotech-
nology, Santa Cruz, CA). Unconjugated anti-MBL-C was detected
by staining with AlexaFluor 546-conjugated donkey anti-goat
secondary antibodies (Invitrogen). Slides were counterstained with
Hoechst 33342 and mounted with Prolong Gold (both from
Invitrogen). 3D image stacks of splenic sections were acquired on a
SP5 confocal microscope (Leica Microsystems). Images are
displayed as 2D maximum intensity projections.
Statistical Analyses
The significance of differences in data group means was
analyzed by Student’s t test or non-parametric Mann Whitney
test with a cut-off of p,0.05.
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